Cellectar (CLRB) Q3 2026 Earnings Call Transcript
Management details the phase III trial and U.S. approval timeline for its lead asset.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
Where To Order Thanksgiving Takeout In New York City
Pre order your entire Thanksgiving feasts or leave just the sides to the pros.
Bitdeer (BTDR) Q3 2026 Earnings Call Transcript
Record revenue and a $2.9B AI cloud backlog fueled growth despite a wider loss.
Bessent urges US, China to ‘de-risk, not decouple’ as Xie points to ‘red lines’
US Treasury Secretary Scott Bessent called for a more balanced trade relationship with China, with the objective to “de-risk, not decouple”, as Chinese ambassador Xie Feng spoke of adhering to “red…
Stocks to focus today: Gokaldas Exports, Matrimony.com, BHEL, Bajaj Finserv, Jyothy Lab, IIFL Finance and others
Key updates include debt relief for BHEL, a major capital raise at IIFL Finance, and strategic stake acquisitions and buyback moves across the portfolio
Q2 Results Today Live: Tata Power, Hindustan Copper, GRSE, Lalithaa Jewellery, MIDHANI to announce Q2 results, Cochin Shipyard, MRF, Kalyan Jewellers, Avanti Feeds, Titagarh Rail, MMTC shares in focus
Q2 Results Today, 11th November 2026 Live Updates: businessline brings you the latest quarterly earnings, outlook and more.
Stereotaxis (STXS) Q3 2026 Earnings Call Transcript
Supply constraints and new financing shape the next phase for robotic catheter growth.